Pascal Grondin

2.7k total citations · 1 hit paper
16 papers, 2.1k citations indexed

About

Pascal Grondin is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Pascal Grondin has authored 16 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Surgery. Recurrent topics in Pascal Grondin's work include Phosphodiesterase function and regulation (4 papers), Metabolism, Diabetes, and Cancer (4 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Pascal Grondin is often cited by papers focused on Phosphodiesterase function and regulation (4 papers), Metabolism, Diabetes, and Cancer (4 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Pascal Grondin collaborates with scholars based in France, Switzerland and Canada. Pascal Grondin's co-authors include Bronwyn D. Hegarty, Michael Snowden, Matthew J. Sanders, David Carling, Nicolas Ancellin, Hervé Coste, Alain Daugan, Anne‐Charlotte Le Monnier de Gouville, François Hyafil and Richard Labaudinière and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and Biochemical Journal.

In The Last Decade

Pascal Grondin

16 papers receiving 2.0k citations

Hit Papers

Investigating the mechanism for AMP activation of the AMP... 2007 2026 2013 2019 2007 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Grondin France 14 1.4k 478 313 294 270 16 2.1k
My‐Hanh Lam United States 21 857 0.6× 717 1.5× 210 0.7× 284 1.0× 193 0.7× 33 2.0k
Mark C. Kowala United States 24 640 0.5× 618 1.3× 273 0.9× 362 1.2× 106 0.4× 56 1.9k
Louis Douste‐Blazy France 33 1.7k 1.2× 556 1.2× 335 1.1× 606 2.1× 269 1.0× 159 3.3k
Jan Fleckner Denmark 24 1.4k 1.0× 398 0.8× 247 0.8× 401 1.4× 118 0.4× 43 2.1k
Susan Butler United States 9 653 0.5× 704 1.5× 246 0.8× 283 1.0× 96 0.4× 16 2.7k
Lawrence M. Ballas United States 24 2.2k 1.6× 306 0.6× 216 0.7× 226 0.8× 215 0.8× 37 3.5k
Zhongzhou Shen United States 20 1.1k 0.8× 282 0.6× 90 0.3× 363 1.2× 96 0.4× 28 2.6k
P K Weech Canada 26 1.1k 0.8× 604 1.3× 566 1.8× 280 1.0× 285 1.1× 44 2.2k
Montserrat Miralpeix Spain 28 2.4k 1.7× 511 1.1× 448 1.4× 1.0k 3.5× 164 0.6× 81 4.1k
Birgitta Rosengren Sweden 26 1.1k 0.8× 563 1.2× 329 1.1× 227 0.8× 71 0.3× 42 2.4k

Countries citing papers authored by Pascal Grondin

Since Specialization
Citations

This map shows the geographic impact of Pascal Grondin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Grondin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Grondin more than expected).

Fields of papers citing papers by Pascal Grondin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Grondin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Grondin. The network helps show where Pascal Grondin may publish in the future.

Co-authorship network of co-authors of Pascal Grondin

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Grondin. A scholar is included among the top collaborators of Pascal Grondin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Grondin. Pascal Grondin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Karoyan, Philippe, Vincent Vieillard, Amélie Guihot, et al.. (2021). Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection. Communications Biology. 4(1). 197–197. 93 indexed citations
2.
Levasseur, Mikail D., Yann Lamotte, Nicolas Ancellin, et al.. (2019). Homotrimerization Approach in the Design of Thrombospondin-1 Mimetic Peptides with Improved Potency in Triggering Regulated Cell Death of Cancer Cells. Journal of Medicinal Chemistry. 62(17). 7656–7668. 4 indexed citations
3.
Schlemmer, Dimitri, Jean‐François Benoist, Pascal Grondin, et al.. (2018). A new AMPK activator, GSK773, corrects fatty acid oxidation and differentiation defect in CPT2-deficient myotubes. Human Molecular Genetics. 27(19). 3417–3433. 13 indexed citations
4.
Martínez‐Torres, Ana Carolina, Claire Quiney, Mikail D. Levasseur, et al.. (2016). Thrombospondin-1 Mimetic Agonist Peptides Induce Selective Death in Tumor Cells: Design, Synthesis, and Structure–Activity Relationship Studies. Journal of Medicinal Chemistry. 59(18). 8412–8421. 19 indexed citations
5.
Mirguet, Olivier, Jérôme Toum, Pascal Huet, et al.. (2013). Discovery of Pyridones As Oral AMPK Direct Activators. ACS Medicinal Chemistry Letters. 4(7). 632–636. 14 indexed citations
6.
Sanders, Matthew J., Pascal Grondin, Bronwyn D. Hegarty, Michael Snowden, & David Carling. (2007). Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochemical Journal. 403(1). 139–148. 525 indexed citations breakdown →
7.
Brusq, Jean‐Marie, et al.. (2006). Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. Journal of Lipid Research. 47(6). 1281–1288. 288 indexed citations
8.
Foretz, Marc, Nicolas Ancellin, Fabrizio Andréelli, et al.. (2005). Short-Term Overexpression of a Constitutively Active Form of AMP-Activated Protein Kinase in the Liver Leads to Mild Hypoglycemia and Fatty Liver. Diabetes. 54(5). 1331–1339. 323 indexed citations
9.
Daugan, Alain, Pascal Grondin, Anne‐Charlotte Le Monnier de Gouville, et al.. (2003). The Discovery of Tadalafil:  A Novel and Highly Selective PDE5 Inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1‘,2‘:1,6]pyrido[3,4-b]indole-1,4-dione Analogues. Journal of Medicinal Chemistry. 46(21). 4533–4542. 244 indexed citations
10.
Daugan, Alain, Pascal Grondin, Anne‐Charlotte Le Monnier de Gouville, et al.. (2003). The Discovery of Tadalafil:  A Novel and Highly Selective PDE5 Inhibitor. 1: 5,6,11,11a-Tetrahydro-1H-imidazo[1‘,5‘:1,6]pyrido[3,4-b]indole-1,3(2H)-dione Analogues. Journal of Medicinal Chemistry. 46(21). 4525–4532. 164 indexed citations
11.
Grondin, Pascal, et al.. (1998). Effect of a cGMP-specific phosphodiesterase inhibitor on retinal function. European Journal of Pharmacology. 352(2-3). 157–163. 18 indexed citations
12.
Coste, Hervé & Pascal Grondin. (1995). Characterization of a novel potent and specific inhibitor of type v phosphodiesterase. Biochemical Pharmacology. 50(10). 1577–1585. 58 indexed citations
13.
Plantavid, Monique, Christilla Bachelot‐Loza, Pascal Grondin, et al.. (1991). Involvement of platelet glycoprotein IIb-IIIa (alpha IIb-beta 3 integrin) in thrombin-induced synthesis of phosphatidylinositol 3‘,4‘-bisphosphate.. Journal of Biological Chemistry. 266(35). 23554–23557. 83 indexed citations
14.
Grondin, Pascal, et al.. (1991). Interaction of pp60c-src, phospholipase C, inositol-lipid, and diacyglycerol kinases with the cytoskeletons of thrombin-stimulated platelets. Journal of Biological Chemistry. 266(24). 15705–15709. 169 indexed citations
15.
Grondin, Pascal, et al.. (1990). Purification and characterization of a novel phospholipid transfer protein from filamentous fungi. International Journal of Biochemistry. 22(1). 93–98. 10 indexed citations
16.
Breton, M, et al.. (1990). The novel inositol lipid phosphatidylinositol 3,4-bisphosphate is produced by human blood platelets upon thrombin stimulation. Biochemical Journal. 269(3). 831–834. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026